Eri Kawashita Selected Research

G(M2) Ganglioside (Ganglioside GM2)

1/2016	Enhancement by Uridine Diphosphate of Macrophage Inflammatory Protein-1 Alpha Production in Microglia Derived from Sandhoff Disease Model Mice.
1/2011	Prostaglandin E2 reverses aberrant production of an inflammatory chemokine by microglia from Sandhoff disease model mice through the cAMP-PKA pathway.
6/2009	Abnormal production of macrophage inflammatory protein-1alpha by microglial cell lines derived from neonatal brains of Sandhoff disease model mice.
8/2006	Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eri Kawashita Research Topics

Disease

6	Fibrosis (Cirrhosis) 01/2023 - 01/2010
4	Sandhoff Disease (Sandhoff's Disease) 01/2016 - 08/2006
3	Down Syndrome (Down's Syndrome) 01/2023 - 01/2019
3	Inflammation (Inflammations) 01/2019 - 02/2016
2	Cognitive Dysfunction 01/2023 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2019 - 03/2016
1	Alcoholic Fatty Liver 04/2022
1	Weight Gain 01/2019
1	Fatty Liver 03/2016
1	Bone Resorption 01/2016
1	Bone Diseases (Bone Disease) 03/2011
1	Systemic Scleroderma (Systemic Sclerosis) 01/2010
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 08/2006

Drug/Important Bio-Agent (IBA)

5	Group IV Phospholipases A2IBA 01/2023 - 02/2016
4	G(M2) Ganglioside (Ganglioside GM2)IBA 01/2016 - 08/2006
3	CopperIBA 01/2023 - 01/2019
2	CholesterolIBA 01/2019 - 03/2016
2	LipidsIBA 01/2019 - 03/2016
2	Hexosaminidases (Hexosaminidase)IBA 01/2016 - 01/2011
2	Bleomycin (Blenoxane)FDA LinkGeneric 02/2013 - 01/2010
2	OligosaccharidesIBA 01/2011 - 06/2009
2	beta-N-AcetylhexosaminidasesIBA 06/2009 - 08/2006
1	CollagenIBA 01/2023
1	MetalsIBA 01/2023
1	picric acid (picrate)IBA 04/2022
1	EicosanoidsIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	LysophospholipidsIBA 01/2019
1	3- (1- (4- phenoxyphenyl)- 3- (2- phenylethyl)- 1H- indol- 5- yl)propanoic acidIBA 03/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2016
1	PropaneIBA 03/2016
1	PropionatesIBA 03/2016
1	SaltsIBA 03/2016
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Uridine Diphosphate (UDP)IBA 01/2016
1	Prostaglandins FIBA 02/2013
1	ProstaglandinsIBA 02/2013
1	Phospholipases (Phospholipase)IBA 02/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013
1	Lipase (Acid Lipase)FDA Link 02/2013
1	CalciumIBA 02/2013
1	Calcium-Independent Phospholipases A2IBA 02/2013
1	Dinoprostone (PGE2)FDA Link 01/2011
1	ChemokinesIBA 01/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2010
1	AcetylglucosamineIBA 06/2009
1	Therapeutic UsesIBA 08/2006

Therapy/Procedure

2	Therapeutics 03/2011 - 01/2010
1	Diet Therapy (Therapy, Diet) 01/2023
1	Drug Therapy (Chemotherapy) 01/2023